acetazolamide/tetrahydrocannabinol (IHL-42X) / Incannex 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
acetazolamide/tetrahydrocannabinol (IHL-42X) / Incannex
ACTRN12619001103156p: The effects of novel medicinal cannabis formulation IHL-42X on apnoea hypopnea index in adults with suspected or diagnosed mild to moderate obstructive sleep apnoea.

Not yet recruiting
2/3
30
 
Cannvalate, Cannvalate
Obstructive Sleep Apnoea
 
 
ACTRN12619001103156: The effects of novel medicinal cannabis formulation IHL-42X on apnoea hypopnea index in adults with suspected or diagnosed mild to moderate obstructive sleep apnoea.

Not yet recruiting
2/3
30
 
Cannvalate, Cannvalate
Obstructive Sleep Apnoea
 
 
REPOSA, NCT06146101: RePOSA-Revealing the Efficacy of IHL-42X Use in Patients with OSA

Recruiting
2/3
560
US
IHL-42X Low Dose, Phase 2 Investigational Product - IHL-42X Low dose, IHL-42X High Dose, Phase 2 Investigational Product - IHL-42X High dose, Placebo, Phase 2 Placebo, IHL-42X (Optimal Dose), Phase 3 Investigational Product - IHL-42X, Dronabinol, Phase 3 Comparator - Reference Listed Drug/Dronabinol, Acetazolamide, Phase 3 Comparator - Reference Listed Drug/Acetazolamide, Phase 3 Placebo
Incannex Healthcare Ltd
Obstructive Sleep Apnea
12/26
12/26
ACTRN12620000916943: Proof of concept study on the combined effect of dronabinol and acetazolamide on apnoea hypopnoea index (AHI) in adults with obstructive sleep apnoea

Completed
2
12
 
Incannex Healthcare Limited, Incannex Healthcare Limited
Obstructive Sleep Apnoea
 
 
ACTRN12621000809831p: An Open Label Extension on the Examination of the Combination of Dronabinol and Acetazolamide for Treatment of Obstructive Sleep Apnoea (OSA)

Not yet recruiting
1/2
12
 
Incannex Healthcare Ltd, Incannex Healthcare Ltd
Obstructive Sleep Apnoea
 
 
ACTRN12621000809831: An Open Label Extension on the Examination of the Combination of Dronabinol and Acetazolamide for Treatment of Obstructive Sleep Apnoea (OSA)

Terminated
1/2
12
 
Incannex Healthcare Ltd, Incannex Healthcare Ltd
Obstructive Sleep Apnoea
 
 
NCT05857384: Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs

Active, not recruiting
1
116
RoW
IHL42X, IHL-42X, Acetazolamide 250 MG, Taro Acetazolamide, Dronabinol 2.5 MG, Marinol
Incannex Healthcare Ltd
Obstructive Sleep Apnea
12/24
12/24

Download Options